- by sedlv
- June 12 2025
Summary – Ross has developed proprietary technology to mine microbiomes, already discovering 110,000+ novel small molecules with potential applications across pharmaceuticals, agriculture, and beyond.
Why investors should tune in:
– First-mover advantage in an untapped market
– Technology validated by Los Alamos National Lab
– Platform business model with multiple revenue streams
– Potential to generate 4X the human knowledge on microbial molecules annually
Ross brings exceptional credentials as a serial entrepreneur who’s built Inc. 500 companies and secured backing from DARPA, NIH, and major research institutions.